Replies to post #58 on Fulgent Genetics, Inc. (FLGT)

[Raptor17]

The latest numbers suggest price to cash is 7 vs an industry 18. The revenue growth is projected to continue with Q1 projected at 77% of 2020. They just announced the CDC NGS contract - can we expect an upward revision of the Q1 revs?